Main Conference Day 3Wednesday, 16 December 2026 - PT (Pacific Time, GMT-08:00)

As multispecific antibody technologies become increasingly competitive, creating valuable intellectual property requires more than protecting individual molecules. This presentation explores how antibody engineers can identify, generate, and support patentable innovations across molecular design, functionality, manufacturing, and platform technologies. Attendees will gain practical insights into building layered patent portfolios that maximize commercial value, strengthen competitive positioning, and support long-term innovation leadership.